Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
JMIR Formative Research|March 31, 2022
Mobile App Intervention on Reducing the Myeloproliferative Neoplasm Symptom Burden: Pilot Feasibility and Acceptability StudyHninyee Win, Samantha Russell, Betsy C Wertheim, et al.
Blood|June 7, 2019
Oral idasanutlin in patients with polycythemia veraJohn Mascarenhas, Min Lu, Heidi Kosiorek, et al.
Cancer|April 12, 2023
Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasmsRaoul Tibes, Heidi E Kosiorek, Amylou C Dueck, et al.
Cancer|December 22, 2005
The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia veraAyalew Tefferi, Terra L Lasho, Susan M Schwager, et al.
Blood|November 7, 2024
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigmAnthony M Hunter, Mrinal M Patnaik, Raphael Itzykson, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2019
Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL StudyMichael R Grunwald, John M Burke, David J Kuter, et al.
Haematologica|January 19, 2011
The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issuesRichard A Van Etten, Steffen Koschmieder, Francois Delhommeau, et al.
Leukemia & Lymphoma|September 21, 2018
Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosisKamal Menghrajani, Philip S Boonstra, Jessica A Mercer, et al.
Pageof 18